Olaparib did not induce a significant increase in PD-L1 expression in DU145 cells, but it can enhance the tumor lysis promoted by high-affinity NK cells or NK cells treated with an IL-15/IL-15 receptor-α superagonists [126]. The gene discussed is IL15; the disease is neoplasm.